MHRA Issues Warning Against Rectal Catheters for Infants: What Parents Need to Know

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a critical Device Safety Information (DSI) notice, cautioning healthcare professionals, parents, and caregivers against the use of rectal catheters, specifically those designed for gas and colic relief in infants.

These devices are often employed by parents and caregivers to alleviate issues such as colic, constipation, or trapped wind in babies. They can be purchased online and in retail outlets without the requirement for a prescription.

Concerns Over Efficacy and Safety

Following a thorough review of existing evidence and expert clinical guidance, the MHRA has determined that there is inadequate evidence supporting the efficacy of these devices for their intended purpose. Additionally, the agency has raised concerns regarding the potential risks associated with their use.

The MHRA strongly advises that parents, caregivers, and healthcare professionals refrain from using or recommending these products for infants. Furthermore, any rectal catheters that have already been acquired should be disposed of safely.

Although no confirmed cases of serious injury linked to these devices have been reported, uncertainty surrounds their safety and effectiveness. Experts have expressed concerns that the use of these products may obscure the diagnosis of underlying medical conditions that require attention. There is also the potential risk of injury to the rectal area, including tearing or perforation, which could lead to severe complications.

Expert Recommendations and Guidance

Dr Alison Cave, Chief Safety Officer at the MHRA, stated, “We understand that colic and digestive discomfort can be distressing for babies and their families. We are advising against the use of rectal catheters in babies because there is not enough clinical evidence to support their safety and effectiveness.”

She continued, “Parents and caregivers should seek advice from a healthcare professional and follow NHS guidelines if they have concerns about their baby.”

Individuals encountering issues with a medical device or suspecting that their child has experienced side effects related to the use of rectal catheters are encouraged to report these incidents directly to the MHRA Yellow Card scheme.

Further Information on Regulatory Oversight

The DSI notice is available for further review, providing comprehensive details on the advisory against rectal catheters intended for gas and colic relief in infants.

The MHRA is tasked with the regulation of all medicines and medical devices within the UK, ensuring their efficacy and safety. The agency’s operations are founded on robust, evidence-based assessments to ensure that the benefits of medical products outweigh any associated risks.

As an executive agency under the Department of Health and Social Care, the MHRA remains committed to safeguarding public health and informing consumers and professionals alike.

For media inquiries, please reach out to the provided contact information for the MHRA.